Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia
- PMID: 21150180
- DOI: 10.1159/000322120
Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia
Abstract
The severe endothelial dysfunction in children with acute lymphoblastic leukemia (ALL) can result from the disease itself, from treatment, or from other conditions (e.g. sepsis). The aim of this study was to determine the levels of markers of endothelial activation in children with ALL and to assess their potential prognostic value. Fifty-two children with ALL, 19 children with ALL 1-10 years after the completion of therapy, and 28 healthy children were studied. In children with ALL, there was a significant increase in thrombomodulin (TM) and von Willebrand factor (vWF) levels during the acute phase of the disease and during treatment. Children with an unfavorable outcome had higher levels of TM. In conclusion, severe endothelial dysfunction is present during the acute phase of ALL and during treatment and appears to result from the disease itself. Serum TM and vWF levels might represent additional, but not independent, prognostic markers in childhood ALL.
Copyright © 2010 S. Karger AG, Basel.
Similar articles
-
Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.J Oncol Pharm Pract. 2014 Oct;20(5):356-61. doi: 10.1177/1078155213508439. Epub 2013 Nov 15. J Oncol Pharm Pract. 2014. PMID: 24243921
-
Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.Med Pediatr Oncol. 2003 Jan;40(1):9-12. doi: 10.1002/mpo.10145. Med Pediatr Oncol. 2003. PMID: 12426679
-
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.Am J Cardiol. 2006 Mar 1;97(5):671-5. doi: 10.1016/j.amjcard.2005.09.113. Epub 2006 Jan 10. Am J Cardiol. 2006. PMID: 16490435
-
Endothelial (dys)function in lone atrial fibrillation.Curr Pharm Des. 2015;21(5):622-45. doi: 10.2174/1381612820666140825143028. Curr Pharm Des. 2015. PMID: 25175088 Review.
-
[Markers of endothelial dysfunction: pathogenetic role and diagnostic significance.].Klin Lab Diagn. 2019;64(1):34-41. doi: 10.18821/0869-2084-2018-63-34-41. Klin Lab Diagn. 2019. PMID: 30912882 Review. Russian.
Cited by
-
The role of VWF/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies.J Thromb Haemost. 2022 Aug;20(8):1766-1777. doi: 10.1111/jth.15773. Epub 2022 Jun 23. J Thromb Haemost. 2022. PMID: 35644028 Free PMC article. Review.
-
Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy.Int J Mol Sci. 2019 Jan 8;20(1):214. doi: 10.3390/ijms20010214. Int J Mol Sci. 2019. PMID: 30626079 Free PMC article.
-
A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification.Cell Res. 2012 Jun;22(6):986-1002. doi: 10.1038/cr.2012.4. Epub 2012 Jan 3. Cell Res. 2012. PMID: 22212479 Free PMC article.
-
Vascular endothelial dysfunction after anthracyclines treatment in children with acute lymphoblastic leukemia.Korean J Pediatr. 2013 Mar;56(3):130-4. doi: 10.3345/kjp.2013.56.3.130. Epub 2013 Mar 18. Korean J Pediatr. 2013. PMID: 23559975 Free PMC article.
-
Endothelial Function in Children with Acute Lymphoblastic Leukemia (ALL) May Reflect the Clinical Outcome.Biomed Res Int. 2018 Nov 11;2018:7918091. doi: 10.1155/2018/7918091. eCollection 2018. Biomed Res Int. 2018. PMID: 30534565 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous